155 related articles for article (PubMed ID: 37789785)
1. Unraveling the complexity: A comprehensive analysis of the PP2A in cancer and its potential for novel targeted therapies.
Ivovič D; Kabelíková P; Jurkovičová D
Neoplasma; 2023 Aug; 70(4):485-499. PubMed ID: 37789785
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of PP2A.
O'Connor CM; Perl A; Leonard D; Sangodkar J; Narla G
Int J Biochem Cell Biol; 2018 Mar; 96():182-193. PubMed ID: 29107183
[TBL] [Abstract][Full Text] [Related]
3. Targeting PP2A in cancer: Combination therapies.
Mazhar S; Taylor SE; Sangodkar J; Narla G
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):51-63. PubMed ID: 30401535
[TBL] [Abstract][Full Text] [Related]
4. All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.
Sangodkar J; Farrington CC; McClinch K; Galsky MD; Kastrinsky DB; Narla G
FEBS J; 2016 Mar; 283(6):1004-24. PubMed ID: 26507691
[TBL] [Abstract][Full Text] [Related]
5. Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.
Haanen TJ; O'Connor CM; Narla G
J Biol Chem; 2022 Dec; 298(12):102656. PubMed ID: 36328247
[TBL] [Abstract][Full Text] [Related]
6. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
Dzulko M; Pons M; Henke A; Schneider G; Krämer OH
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188453. PubMed ID: 33068647
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer.
Seshacharyulu P; Pandey P; Datta K; Batra SK
Cancer Lett; 2013 Jul; 335(1):9-18. PubMed ID: 23454242
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase 2A: a target for anticancer therapy.
Perrotti D; Neviani P
Lancet Oncol; 2013 May; 14(6):e229-38. PubMed ID: 23639323
[TBL] [Abstract][Full Text] [Related]
9. The interaction of SET and protein phosphatase 2A as target for cancer therapy.
Dacol EC; Wang S; Chen Y; Lepique AP
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173
[TBL] [Abstract][Full Text] [Related]
10. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
[TBL] [Abstract][Full Text] [Related]
11. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells.
Janssens V; Rebollo A
Curr Mol Med; 2012 Mar; 12(3):268-87. PubMed ID: 22300139
[TBL] [Abstract][Full Text] [Related]
12. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.
Qi Y; Li L; Wei Y; Ma F
Biomed Pharmacother; 2024 Apr; 173():116398. PubMed ID: 38458011
[TBL] [Abstract][Full Text] [Related]
13. Regulation and role of the PP2A-B56 holoenzyme family in cancer.
Peris I; Romero-Murillo S; Vicente C; Narla G; Odero MD
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188953. PubMed ID: 37437699
[TBL] [Abstract][Full Text] [Related]
14. PP2A and tumor radiotherapy.
Lei X; Ma N; Du L; Liang Y; Zhang P; Han Y; Qu B
Hereditas; 2020 Aug; 157(1):36. PubMed ID: 32847617
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
16. PP2A-B55 Holoenzyme Regulation and Cancer.
Goguet-Rubio P; Amin P; Awal S; Vigneron S; Charrasse S; Mechali F; Labbé JC; Lorca T; Castro A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33266510
[TBL] [Abstract][Full Text] [Related]
17. Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.
Nematullah M; Hoda MN; Khan F
Mol Neurobiol; 2018 Feb; 55(2):1750-1761. PubMed ID: 28224476
[TBL] [Abstract][Full Text] [Related]
18. Roles and regulation of protein phosphatase 2A (PP2A) in the heart.
Lubbers ER; Mohler PJ
J Mol Cell Cardiol; 2016 Dec; 101():127-133. PubMed ID: 27832939
[TBL] [Abstract][Full Text] [Related]
19. Targeting PP2A for cancer therapeutic modulation.
Ronk H; Rosenblum JS; Kung T; Zhuang Z
Cancer Biol Med; 2022 Nov; 19(10):1428-39. PubMed ID: 36342229
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic relevance of the protein phosphatase 2A in cancer.
Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
